(Q44356788)

2 December 2017

title

Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D. (English)

1 reference

2 December 2017

0 references

1 reference

Rajendra G Mehta

1

1 reference

2 December 2017

Erum A Hussain

series ordinal

2

1 reference

2 December 2017

Rajeshwari R Mehta

series ordinal

3

1 reference

2 December 2017

Tapas K Das Gupta

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

523-524

1 reference

2 December 2017

page(s)

253-264

1 reference

Recent advances in chemoprevention of cancer

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Multiple points of intervention in the prevention of cancer and other mutation-related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Breast cancer chemoprevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Cancer chemoprevention: progress and promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Differentiation therapy in acute myelogenous leukemia (non-APL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Novel side chain analogs of 1alpha,25-dihydroxyvitamin D(3): design and synthesis of the 21,24-methano derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Synthesis of vitamin D5: Its biological activity relative to vitamins D3 and D2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Vitamin D receptors: nature and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Vitamin D3 receptors: structure and function in transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Current understanding of the molecular actions of vitamin D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Rapid and genomic biological responses are mediated by different shapes of the agonist steroid hormone, 1alpha,25(OH)2vitamin D3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Mannheim classification of nongenomically initiated (rapid) steroid action(s).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Induction of atypical ductal hyperplasia in mouse mammary gland organ culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Cancer chemoprevention using natural vitamin D and synthetic analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

The role of vitamin D3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900341-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0027-5107(02)00341-X

1 reference

2 December 2017

1 reference